Rankings
▼
Calendar
MNKD Q4 2017 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$841M
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
-63.5% YoY
Gross Profit
-$488,000
-10.8% margin
Operating Income
-$29M
-636.6% margin
Net Income
-$33M
-723.7% margin
EPS (Diluted)
$-0.28
QoQ Revenue Growth
+121.7%
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$30M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$85M
Total Liabilities
$299M
Stockholders' Equity
-$215M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$12M
-63.5%
Gross Profit
-$488,000
$621,000
-178.6%
Operating Income
-$29M
-$12M
-143.7%
Net Income
-$33M
$54M
-160.7%
Revenue Segments
Product
$3M
100%
← FY 2017
All Quarters
Q1 2018 →